RedHill Biopharma RDHL
NASDAQ RDHL
$0.46 -0.05 (-10.31%)
As of: Oct 21, 2026 · 3:45 PM EDT

RedHill Biopharma (RDHL) Total Non-Current Liabilities (2011 - 2026)

Updated

RedHill Biopharma (RDHL) reported Total Non-Current Liabilities of $1.79 million for the quarter ended Jun 30, 2026, up 258.4% from $500,000 a year earlier.

Analysis

RedHill Biopharma (RDHL) Total Non-Current Liabilities (2011 - 2026) Analysis & Trends

As of Dec 31, 2025, RedHill Biopharma posted Total Non-Current Liabilities of $1.86 million, up 269.0% from the prior year.

  • Total Non-Current Liabilities has a five-year compound annual growth rate of -54.3% (years ended Dec 2020 to Dec 2025).
  • By year, Total Non-Current Liabilities came in at $503,000 in the year ended Dec 31, 2024 (-49.4%), $995,000 in the year ended Dec 31, 2023 (-89.9%), $9.82 million in the year ended Dec 31, 2022 (-88.3%) and $83.62 million in the year ended Dec 31, 2021 (-10.2%).
  • Five-year quarterly Total Non-Current Liabilities spans a low of $500,000 in the quarter ended Jun 30, 2025 and a high of $200.29 million in the quarter ended Sep 30, 2022.
  • Year over year, Total Non-Current Liabilities gained in two of the last four quarters, with growth averaging 111.6%.
  • The high point for year-over-year Total Non-Current Liabilities in five years was the quarter ended Dec 31, 2025 (growth of 269.0%); the low point was the quarter ended Dec 31, 2023 (a decline of 89.9%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 60.66 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 105.50 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 106.45 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 80.25 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 48.34 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 33.91 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 78.66 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 35.10 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 97.04 Bn
10 RedHill Biopharma 1.44 Mn -15.18 Mn - 1.79 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.79 Mn
Dec 31, 2025 1.86 Mn
Jun 30, 2025 500,000.00
Dec 31, 2024 503,000.00
Jun 30, 2024 730,000.00
Dec 31, 2023 995,000.00
Jun 30, 2023 3.38 Mn
Mar 31, 2023 55.20 Mn
Dec 31, 2022 9.82 Mn
Sep 30, 2022 200.29 Mn
Jun 30, 2022 13.49 Mn
Dec 31, 2021 90.84 Mn
Jun 30, 2021 94.92 Mn
Dec 31, 2020 93.14 Mn
Jun 30, 2020 95.91 Mn
Dec 31, 2019 3.48 Mn
Sep 30, 2019 17.39 Mn
Jun 30, 2019 3.74 Mn
Mar 31, 2019 14.94 Mn
Dec 31, 2018 844,000.00
API Access

RedHill Biopharma Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RDHL&period=max&api_key=YOUR_API_KEY